Lisa Harinstein

481 total citations
20 papers, 356 citations indexed

About

Lisa Harinstein is a scholar working on Toxicology, Public Health, Environmental and Occupational Health and Surgery. According to data from OpenAlex, Lisa Harinstein has authored 20 papers receiving a total of 356 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Toxicology, 5 papers in Public Health, Environmental and Occupational Health and 4 papers in Surgery. Recurrent topics in Lisa Harinstein's work include Pharmacovigilance and Adverse Drug Reactions (5 papers), Pharmaceutical Practices and Patient Outcomes (4 papers) and Patient Safety and Medication Errors (3 papers). Lisa Harinstein is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (5 papers), Pharmaceutical Practices and Patient Outcomes (4 papers) and Patient Safety and Medication Errors (3 papers). Lisa Harinstein collaborates with scholars based in United States. Lisa Harinstein's co-authors include Sandra L. Kane‐Gill, Pamela L. Smithburger, Joseph Morgan, Amy L. Seybert, Eileen Wu, Jason J. Schafer, Earnest Alexander, Frank d'Amico, Mitchell S. Buckley and Sandeep Devabhakthuni and has published in prestigious journals such as Gastroenterology, American Journal of Public Health and Critical Care Medicine.

In The Last Decade

Lisa Harinstein

19 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lisa Harinstein United States 11 124 83 67 52 47 20 356
Anastasia Rivkin United States 13 118 1.0× 54 0.7× 23 0.3× 66 1.3× 35 0.7× 28 476
Åsmund Reikvam Norway 13 110 0.9× 35 0.4× 153 2.3× 50 1.0× 30 0.6× 61 467
Srečko Marušić Croatia 15 284 2.3× 41 0.5× 128 1.9× 33 0.6× 46 1.0× 38 568
Ahmed Y. Mayet Saudi Arabia 12 211 1.7× 141 1.7× 49 0.7× 42 0.8× 46 1.0× 25 477
Qoua L. Her United States 8 119 1.0× 46 0.6× 45 0.7× 48 0.9× 33 0.7× 23 435
Josep Maria Arnau Spain 10 170 1.4× 38 0.5× 65 1.0× 54 1.0× 132 2.8× 17 490
John G. O’Meara United States 9 154 1.2× 86 1.0× 140 2.1× 33 0.6× 19 0.4× 14 380
Peter C. Wierenga Netherlands 13 230 1.9× 132 1.6× 51 0.8× 53 1.0× 74 1.6× 18 522
Eugenia Yu Canada 8 107 0.9× 58 0.7× 165 2.5× 15 0.3× 80 1.7× 10 409
Abdullah Al Hamid United Kingdom 12 182 1.5× 63 0.8× 47 0.7× 35 0.7× 98 2.1× 28 474

Countries citing papers authored by Lisa Harinstein

Since Specialization
Citations

This map shows the geographic impact of Lisa Harinstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Harinstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Harinstein more than expected).

Fields of papers citing papers by Lisa Harinstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Harinstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Harinstein. The network helps show where Lisa Harinstein may publish in the future.

Co-authorship network of co-authors of Lisa Harinstein

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Harinstein. A scholar is included among the top collaborators of Lisa Harinstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Harinstein. Lisa Harinstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Rongmei, et al.. (2025). An Evaluation of Duplicate Adverse Event Reports Characteristics in the Food and Drug Administration Adverse Event Reporting System. Drug Safety. 48(10). 1119–1126. 1 indexed citations
2.
Harinstein, Lisa, et al.. (2024). The Food and Drug Administration’s Safety Surveillance of Adverse Event Cases Involving Cannabinoid Hemp Products, 2019–2023. American Journal of Public Health. 114(S8). S664–S672. 3 indexed citations
3.
Beganovic, Maya, James M. Kidd, Rachna Kapoor, et al.. (2022). The Food and Drug Administration’s (FDA’s) Drug Safety Surveillance During the COVID-19 Pandemic. Drug Safety. 46(2). 145–155. 8 indexed citations
4.
Biehl, Ann, et al.. (2020). A case series analysis of serious exacerbations of viral hepatitis and non‐viral hepatic injuries in tocilizumab‐treated patients. Liver International. 41(3). 515–528. 8 indexed citations
5.
Harinstein, Lisa, et al.. (2019). Su1599 – Pancreatitis Following Eluxadoline Use: 1-Year Reassessment After Regulatory Action. Gastroenterology. 156(6). S–578.
6.
Harinstein, Lisa, Bhawana Saluja, Mónica Muñoz, et al.. (2019). Drug Interaction Between Febuxostat and Thiopurine Antimetabolites: A Review of the FDA Adverse Event Reporting System and Medical Literature. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 40(2). 125–132. 10 indexed citations
7.
Grenade, Lois La, et al.. (2019). Pruritus after discontinuation of cetirizine. Therapeutic Advances in Drug Safety. 10. 584401948–584401948. 4 indexed citations
8.
Harinstein, Lisa, et al.. (2018). Evaluation of Postmarketing Reports from Industry-Sponsored Programs in Drug Safety Surveillance. Drug Safety. 42(5). 649–655. 14 indexed citations
9.
Harinstein, Lisa, Eileen Wu, & Allen Brinker. (2018). Postmarketing cases of eluxadoline‐associated pancreatitis in patients with or without a gallbladder. Alimentary Pharmacology & Therapeutics. 47(6). 809–815. 16 indexed citations
10.
Sacha, Gretchen L., Heather Torbic, Simon W. Lam, et al.. (2016). 1355: PREDICTORS OF RESPONSE TO FIXED-DOSE VASOPRESSIN IN ADULT PATIENTS WITH SEPTIC SHOCK. Critical Care Medicine. 44(12). 414–414. 11 indexed citations
11.
Bauer, Seth R., et al.. (2016). Antimicrobial Monotherapy versus Combination Therapy for the Treatment of Complicated Intra‐Abdominal Infections. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 36(11). 1138–1144. 13 indexed citations
12.
Irefin, Samuel A., Abraham Sonny, Lisa Harinstein, & Marc J. Popovich. (2014). Postoperative adverse effects after recent or remote lithium therapy. Journal of Clinical Anesthesia. 26(3). 231–234. 3 indexed citations
13.
Lam, Simon W., et al.. (2014). Compliance With Institutional Antimicrobial Dosing Guidelines in Patients Receiving Continuous Venovenous Hemodialysis. Journal of Pharmacy Practice. 28(4). 380–386. 2 indexed citations
14.
Harinstein, Lisa, et al.. (2013). Improving adverse drug event detection in critically ill patients through screening intensive care unit transfer summaries. Pharmacoepidemiology and Drug Safety. 22(5). 510–516. 19 indexed citations
15.
Buckley, Mitchell S., Lisa Harinstein, Pamela L. Smithburger, et al.. (2013). Impact of a Clinical Pharmacy Admission Medication Reconciliation Program on Medication Errors in “High-Risk” Patients. Annals of Pharmacotherapy. 47(12). 1599–1610. 81 indexed citations
16.
Harinstein, Lisa, Sandra L. Kane‐Gill, Pamela L. Smithburger, et al.. (2012). Use of an abnormal laboratory value–drug combination alert to detect drug-induced thrombocytopenia in critically Ill patients. Journal of Critical Care. 27(3). 242–249. 27 indexed citations
17.
Rathbun, R. Chris, E. Kelly Hester, Lindsay M. Arnold, et al.. (2012). Importance of Direct Patient Care in Advanced Pharmacy Practice Experiences. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 32(4). e88–97. 49 indexed citations
18.
Harinstein, Lisa, et al.. (2012). Treatment of Dabigatran-Associated Bleeding. Journal of Pharmacy Practice. 26(3). 264–269. 44 indexed citations
19.
Harinstein, Lisa, Jason J. Schafer, & Frank d'Amico. (2011). Risk factors associated with the conversion of meticillin-resistant Staphylococcus aureus colonisation to healthcare-associated infection. Journal of Hospital Infection. 79(3). 194–197. 23 indexed citations
20.
Sneddon, W. Bruce, Yanmei Yang, Jianming Ba, Lisa Harinstein, & Peter A. Friedman. (2006). Extracellular signal-regulated kinase activation by parathyroid hormone in distal tubule cells. American Journal of Physiology-Renal Physiology. 292(3). F1028–F1034. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anastasia Rivkin Breakdown of academic impact, for papers by Åsmund Reikvam Breakdown of academic impact, for papers by Srečko Marušić Breakdown of academic impact, for papers by Ahmed Y. Mayet Breakdown of academic impact, for papers by Qoua L. Her Breakdown of academic impact, for papers by Josep Maria Arnau Breakdown of academic impact, for papers by John G. O’Meara Breakdown of academic impact, for papers by Peter C. Wierenga Breakdown of academic impact, for papers by Eugenia Yu Breakdown of academic impact, for papers by Abdullah Al Hamid
Rankless by CCL
2026